Divalproex Sodium Capsule, Coated Pellets
Product Images NDC 68382-106

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 68382-106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

9d7218ee 8cd9 4fe2 Be42 9c9737af62ed 01

FDA Label Image

9d7218ee 8cd9 4fe2 Be42 9c9737af62ed 02

9d7218ee 8cd9 4fe2 Be42 9c9737af62ed 02
The text describes a graph or chart showing the reduction in CPS (presumably referring to seizures) rate for a medication called Divalproex Sodium and a placebo. The graph shows the percentage of patients experiencing improvement, no change, or worsening. No other information is available.*
FDA Label Image

9d7218ee 8cd9 4fe2 Be42 9c9737af62ed 03

FDA Label Image

9d7218ee 8cd9 4fe2 Be42 9c9737af62ed 04

9d7218ee 8cd9 4fe2 Be42 9c9737af62ed 04
This text provides instructions on how to open and use a capsule for adding sprinkles to soft foods. The capsule has an extra large size to prevent spillage, but it still needs to be handled carefully. To open the capsule, it needs to be twisted gently to separate the top and bottom, over the food where sprinkles will be added. Any spilled capsule contents need to be discarded. Afterwards, the sprinkles should be placed on a small amount of soft food, such as applesauce or pudding, and swallowed immediately without chewing. Drinking water after taking the sprinkle and food mixture is recommended to ensure everything is swallowed, and any unused mixture should be thrown away. The instructions advise for the capsule to be used each time right before it is taken.*
FDA Label Image

9d7218ee 8cd9 4fe2 Be42 9c9737af62ed 05

9d7218ee 8cd9 4fe2 Be42 9c9737af62ed 05
This is a packaging label for Divalproex Sodium Delayed-Release Capsules, USP used to treat seizures, bipolar disorder, and migraines. It contains 100 capsules with each capsule containing Divalproex sodium, USP equivalent to valproic acid activity of 125mg. The capsules can be swallowed or opened and sprinkled on food. The label contains instructions for proper storage and administration, a warning to keep it out of the reach of children, and information about the manufacturer and distributor. It also instructs to dispense the medication with the medication guide provided separately to each patient.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.